Suppr超能文献

作为天然产物药物发现靶点的DNA G-四链体

DNA G-Quadruplexes as Targets for Natural Product Drug Discovery.

作者信息

Wang Kai-Bo, Wang Yingying, Dickerhoff Jonathan, Yang Danzhou

机构信息

Borch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47907, USA.

Jiangsu Key Laboratory of Bioactive Natural Product Research & State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Engineering (Beijing). 2024 Jul;38:39-51. doi: 10.1016/j.eng.2024.03.015. Epub 2024 May 6.

Abstract

DNA guanine (G)-quadruplexes (G4s) are unique secondary structures formed by two or more stacked G-tetrads in G-rich DNA sequences. These structures have been found to play a crucial role in highly transcribed genes, especially in cancer-related oncogenes, making them attractive targets for cancer therapeutics. Significantly, targeting oncogene promoter G4 structures has emerged as a promising strategy to address the challenge of undruggable and drug-resistant proteins, such as MYC, BCL2, KRAS, and EGFR. Natural products have long been an important source of drug discovery, particularly in the fields of cancer and infectious diseases. Noteworthy progress has recently been made in the discovery of naturally occurring DNA G4-targeting drugs. Numerous DNA G4s, such as -G4, -G4, -G4, -G4, -G4, and telomeric-G4, have been identified as potential targets of natural products, including berberine, telomestatin, quindoline, sanguinarine, isaindigotone, and many others. Herein, we summarize and evaluate recent advancements in natural and nature-derived DNA G4 binders, focusing on understanding the structural recognition of DNA G4s by small molecules derived from nature. We also discuss the challenges and opportunities associated with developing drugs that target DNA G4s.

摘要

DNA鸟嘌呤(G)-四链体(G4s)是由富含G的DNA序列中的两个或更多个堆叠的G-四联体形成的独特二级结构。已发现这些结构在高转录基因中起关键作用,尤其是在与癌症相关的癌基因中,这使得它们成为癌症治疗的有吸引力的靶点。重要的是,靶向癌基因启动子G4结构已成为应对难以成药和耐药蛋白(如MYC、BCL2、KRAS和EGFR)挑战的一种有前景的策略。天然产物长期以来一直是药物发现的重要来源,特别是在癌症和传染病领域。最近在发现天然存在的靶向DNA G4的药物方面取得了显著进展。许多DNA G4s,如-G4、-G4、-G4、-G4、-G4和端粒-G4,已被确定为天然产物的潜在靶点,包括黄连素、端粒抑素、喹多啉、血根碱、靛玉红等。在此,我们总结并评估天然和天然衍生的DNA G4结合剂的最新进展,重点是了解天然来源的小分子对DNA G4s的结构识别。我们还讨论了开发靶向DNA G4s的药物所面临的挑战和机遇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9295/12347789/274c164661a5/nihms-2053195-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验